Neither from words, nor from visions: understanding p-medicine from innovative treatments

Maël Lemoine


Despite its vagueness Personalized, Precision, P4, P5, individualized, stratified medicine—or p-medicine in short—has become an increasingly popular term in biomedical literature. Philosophers have attempted to analyze what these various terms involve and have discussed consequences for medical practices. In this article, I argue that an important question remains unaddressed:  what has made this project of p-medicine convincing to so many? My argument is that without real achievements, it would never have been. I also make the case that these achievements stem from the domain of monoclonal antibodies (mab), a new type of drug that justifies talks of personalized, precise, stratified, etc., medicine. In conclusion, while it may be possible to label any projection in the future of medicine as ‘p-medicine’, it is impossible to overlook mab-medicine as the spearhead.


personalized medicine; precision medicine

Texte intégral :

PDF (English)


ABRAHAMS, Edward, GINSBURG, Geoffrey S., SILVER, Mike. 2005. « The Personalized Medicine Coalition: Goals and Strategies ». American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice, 5 (6), 345‑55.

ADZHUBEI, Ivan A., SCHMIDT, Steffen, PESHKIN, Leonid, RAMENSKY, Vasily E., GERASIMOVA, Anna, BORK, Peer, KONDRASHOV, Alexey S., SUNYAEV, Shamil R.. 2010. « A Method and Server for Predicting Damaging Missense Mutations ». Nature Methods, 7 (4), 248‑49.

BARABÁSI, Albert-László, GULBAHCE, Natali, LOSCALZO, Joseph. 2011. « Network medicine: a network-based approach to human disease ». Nature reviews. Genetics, 12 (1), 56‑68.

BARH Margaret, BLUM Debmalya and MADIGAN Kenneth. 2011. OMICS: Biomedical Perspectives and Applications. Boca Raton, London, New York : CRC Press.

Biomarkers Definitions Working Group. 2001. « Biomarkers and Surrogate Endpoints: Preferred Definitions and Conceptual Framework ». Clinical Pharmacology and Therapeutics, 69 (3), 89‑95.

BOENINK, Marianne. 2010. « Molecular Medicine and Concepts of Disease: The Ethical Value of a Conceptual Analysis of Emerging Biomedical Technologies ». Medicine, Health Care and Philosophy, 13 (1), 11–23.

BONIOLO, Giovanni, NATHAN, Marco J. 2016. Philosophy of Molecular Medicine: Foundational Issues in Research and Practice. London & New York : Routledge.

BRAGAZZI, Nicola L. 2013. « Rethinking Psychiatry with OMICS Science in the Age of Personalized P5 Medicine: Ready for Psychiatome? » Philosophy, Ethics, and Humanities in Medicine, 8 (1), 4.

CANUEL, Vincent, RANCE, Bastien, AVILLACH, Paul, DEGOULET, Patrice, BURGUN, Anita. 2015. « Translational Research Platforms Integrating Clinical and Omics Data: A Review of Publicly Available Solutions ». Briefings in Bioinformatics, 16 (2), 280‑90.

CHADAREVIAN, Soraya de, KAMMINGA, Harmke. 2003. Molecularizing Biology and Medicine: New Practices and Alliances, 1920s to 1970s. 1re éd. London & New York : Taylor & Francis.

CHAN, Isaac S., GINSBURG, Geoffrey S. 2011. « Personalized Medicine: Progress and Promise ». Annual Review of Genomics and Human Genetics, 12, 217‑44.

DE GRANDIS, Giovanni, HALGUNSET, Vidar. 2016. « Conceptual and terminological confusion around personalised medicine: a coping strategy ». BMC Medical Ethics, 17, 43.

DERFUSS, Tobias. 2012. « Personalized Medicine in Multiple Sclerosis: Hope or Reality? » BMC Medicine, 10, 116.

FAN, Jianqing, HAN, Fang, HAN, Liu. 2014. « Challenges of Big Data analysis ». National Science Review, 1 (2), 293‑314.

FISCHER, Tobias, LANGANKE, Martin, MARSCHALL, Paul, MICHL, Susanne. 2015. Individualized Medicine: Ethical, Economical and Historical Perspectives. Dordrecht : Springer.

FLECK, Leonard M. 2010. « Personalized Medicine’s Ragged Edge ». Hastings Center Report, 40 (5), 16–18.

Food and Drug Administration. 2014. Paving the Way for Personalized Medicine: FDA’s Role in a New Era of Medical Product Development. CreateSpace Independent Publishing Platform.

GAMULIN, Stjepan. 2016. « The Forthcoming Era of Precision Medicine ». Acta Medica Academica, 45 (2), 152‑57.

GREEN, Sara, and VOGT, Henrik. 2016. « Personalizing Medicine: Disease Prevention in silico and in socio ». Humana.Mente Journal of Philosophical Studies, 30, 105-35.

GUCHET, Xavier. 2016. La Médecine personnalisée: Un essai philosophique. 1re éd. Paris : Les Belles Lettres.

HEDGECOE, Adam. 2004. The Politics of Personalised Medicine: Pharmacogenetics in the Clinic. New York : Cambridge University Press.

HOOD, Leroy. 2013. « Systems Biology and p4 Medicine: Past, Present, and Future ». Rambam Maimonides Medical Journal, 4 (2), e0012.

HOOD, Leroy, and FLORES, Mauricio. 2012. « A Personal View on Systems Medicine and the Emergence of Proactive P4 Medicine: Predictive, Preventive, Personalized and Participatory ». New Biotechnology, 29 (6), 613‑24.

HOOD, Leroy, and FRIEND, Stephen H. 2011. « Predictive, Personalized, Preventive, Participatory (P4) Cancer Medicine ». Nature Reviews Clinical Oncology, 8 (3), 184‑87.

IDEKER, Trey, GALITSKI, Timothy, HOOD Leroy. 2001. « A New Approach to Decoding Life: Systems Biology ». Annual Review of Genomics and Human Genetics, 2, 343‑72.

INSEL, Thomas R. 2014. « The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for Psychiatry ». The American Journal of Psychiatry, 171 (4), 395‑97.

JUENGST, Eric, MCGOWAN, Michelle L., FISHMAN, Jennifer R., SETTERSTEN, Richard A. 2016. « From “Personalized” to “Precision” Medicine: The Ethical and Social Implications of Rhetorical Reform in Genomic Medicine ». Hastings Center Report, 46 (5), 21‑33.

KAHN, Scott D. 2011. « On the Future of Genomic Data ». Science, 331 (6018), 728‑29.

KATSANIS, Sara Huston, KATSANIS, Nicholas. 2013. « Molecular Genetic Testing and the Future of Clinical Genomics ». Nature Reviews Genetics, 14 (6), 415‑26.

KEATING, Peter, CAMBROSIO, Alberto. 2011. Cancer on Trial: Oncology as a New Style of Practice. Reprint edition. Chicago : University of Chicago Press.

KHOURY, Muin J., GWINN, Marta L., GLASGOW, Russell E., KRAMER, Barnett S. 2012. « A Population Approach to Precision Medicine ». American Journal of Preventive Medicine, 42 (6), 639‑45.

LANGRETH, Robert, WALDHOLZ, Michael. 1999. « New Era of Personalized Medicine: Targeting Drugs for Each Unique Genetic Profile ». The Oncologist, 4 (5), 426‑27.

LI, Aihua, MEYRE, David. 2014. « Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area ». Current Psychiatry Reviews, 10 (2), 118‑32.

LEMOINE, Maël. 2017. « Animal extrapolation in preclinical studies: An analysis of the tragic case of TGN1412 ». Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, 61, 35-45.

MANOLIO, Teri A., CHISHOLM, Rex L., OZENBERGER, Brad, RODEN, Dan M., WILLIAMS, Marc S., WILSON, Richard, BICK, David et al. 2013. « Implementing Genomic Medicine in the Clinic: The Future Is Here ». Genetics in Medicine, 15 (4), 258‑67.

MCCARTHY, Jeanette J., MCLEOD, Howard L., GINSBURG, Geoffrey S. 2013. « Genomic Medicine: A Decade of Successes, Challenges, and Opportunities ». Science Translational Medicine, 5 (189), 189sr4-189sr4.

MNOOKIN, Seth. 2014. « Fighting a One-of-a-Kind Disease ». The New Yorker.

National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease. 2011. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. The National Academies Collection: Reports Funded by National Institutes of Health. Washington (DC) : National Academies Press (US).

POKORSKA-BOCCI, Anna, STEWART, Alison, SAGOO, Gurdeep S., HALL, Alison, KROESE, Mark, BURTON, Hilary. 2014. « “Personalized medicine”: what’s in a name? » Personalized Medicine, 11 (2), 197‑210.

PRAVETTONI, Gabriella, GORINI, Alessandra. 2011. « A P5 Cancer Medicine Approach: Why Personalized Medicine Cannot Ignore Psychology ». Journal of Evaluation in Clinical Practice, 17 (4), 594‑96.

QU, Xiaoyan A., RAJPAL, Deepak K. 2012. « Applications of Connectivity Map in Drug Discovery and Development ». Drug Discovery Today, 17 (23‑24), 1289‑98.

SCHLEIDGEN, Sebastian, KLINGLER, Corinna, BERTRAM, Teresa, ROGOWSKI, Wolf H., MARCKMANN, Georg. 2013. « What is personalized medicine: sharpening a vague term based on a systematic literature review ». BMC Medical Ethics, 14, 55.

SOON, Wendy Weijia, HARIHARAN, Manoj, SNYDER, Michael P. 2013. « High‐throughput Sequencing for Biology and Medicine ». Molecular Systems Biology, 9 (1), 640.

STEVENS, Hallam. 2013. Life Out of Sequence: A Data-driven History of Bioinformatics. Chicago : University of Chicago Press.

STRIMBU, Kyle, TAVEL, Jorge A. 2010. « What are Biomarkers? » Current opinion in HIV and AIDS, 5 (6), 463‑66.

TANNOCK, Ian F., HICKMAN, John A. 2016. « Limits to Personalized Cancer Medicine ». New England Journal of Medicine, 375 (13), 1289‑94.

TRUSHEIM, Mark R., BERNDT, Ernst R., DOUGLAS, Frank L. 2007. « Stratified Medicine: Strategic and Economic Implications of Combining Drugs and Clinical Biomarkers ». Nature Reviews. Drug Discovery, 6 (4), 287‑93.

TUTTON, Richard. 2012. « Personalizing Medicine: Futures Present and Past ». Social Science & Medicine (1982), 75 (10), 1721‑28.

WORTHEY, Elizabeth A., MAYER, Alan N., SYVERSON, Grant D., HELBLING, Daniel, BONACCI, Benedetta B., DECKER, Brennan, SERPE, Jaime M. et al. 2011. « Making a Definitive Diagnosis: Successful Clinical Application of Whole Exome Sequencing in a Child with Intractable Inflammatory Bowel Disease ». Genetics in Medicine: Official Journal of the American College of Medical Genetics, 13 (3), 255‑62.



  • Il n'y a présentement aucun renvoi.

Lato Sensu est publiée par la Société de philosophie des sciences